DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

Getting ahead of the digital health avalanche How can a health system know which innovative tools are worth its time?

Half of radiologists have net worth of $2 million or more New survey analyzed responses from over 20,000 physicians in over 30 specialties

Varian to acquire Cancer Treatment Services International for $283 million Enables production of multidisciplinary solutions

FBI opens probe into alleged kickbacks by healthcare OEMs in Brazil Accused of making bribes to sell medical equipment

icometrix raises $18 million in funding Will help with deployment of icobrain software in Europe

Q&A with Michael Darling, VP Supply Chain, St. Luke’s Health System Discussing the clinical integration of supply chain

Consolidation, consumerism and telehealth are the top three industry trends for 2019 According to a wide sampling of 1,000 healthcare stakeholders

Varian acquires CyberHeart, enters cardiac radioablation market Emerging technology could benefit treatment of irregular heartbeats

M&A trend lines in tech-enabled medical devices Connecting the dots on industry consolidation

Siemens' push to install Atellica systems may hurt full-year profits Still, Q2 growth 'clearly accelerated'

GE Healthcare IPO on hold as new deal takes spotlight

por Thomas Dworetzky , Contributing Reporter
GE chairman and CEO Larry Culp has said that in light of its just-announced deal with Danaher, the IPO for its healthcare division might be on hold.

“An IPO [for GE's healthcare unit] in 2019 looks unlikely at this point,” Culp told CNBC.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



That's due to its present focus on the sale of the GE Life Sciences unit to Danaher, where it will become a standalone business combined with Danaher's Life Science, according to CNBC.

That deal is worth $21.4 billion – $21 billion in cash and the assumption of some GE pension costs. That's good news for Wall Street; as of year-end 2018, pensions accounted for $21 billion of the company's $55 billion in industrial debt, CNBC reported.

But some reports that the healthcare IPO is not ever going to happen are erroneous, the news station advised.

Instead, it is just delayed because, Culp told CNBC's Morgan Brennan, “we are focused on completing the [Danaher] carve out – which is 15 percent of the $20 billion healthcare segment – and focused on managing the remaining core business.”

Despite the interest in doing a health unit IPO in order to let GE focus on its core businesses, the interest in the biopharma unit presented too good an opportunity to miss.

“IPO of healthcare was Plan A, but we got lots of inbound calls about this business and this is clearly a superior path,” Culp told CNBC’s David Faber.

The Danaher deal is a big help for GE's debt-cutting efforts, with CNBC stating that Cowen Research said in a note that the deal offered “a rich valuation that goes a long way toward GE’s debt reduction.”

Credit Suisse also weighed in, calling the sale of biopharma “a positive” and adding that, “under CEO Culp, GE has been accelerating its strategy to strengthen and deleverage the balance sheet.”

Culp sat atop Danaher as CEO and president from 2000 to 2014, joining the GE board in April, 2018, and becoming GE Chairman and CEO when he replaced John Flannery in October, 2018. In April, 2018, Danaher expressed interest it taking the GE Life Sciences unit, said CNBC, citing the Wall Street Journal.

In January, Culp was touting the healthcare unit sale in a post-earnings conference call after GE's above-expectations Q4 revenue was revealed on the call, when he stated, “we expect to monetize just up to under 50 percent of our healthcare business,” adding that the unit “continues to prepare for public company separation, and that is progressing very well," according to CNBC.
  Pages: 1 - 2 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente a Sua Perceção da Marca
Leilões + Vendas Privadas
Comece
O mais melhor preço
Comprar Equipamento/Peças
Encontre
O preço o mais baixo
Notícia diária
Leia
A notícia a mais atrasada
Diretório
Browse tudo
DOTmed Usuários
Ética no DOTmed
Veja o nosso
Programa das éticas
O ouro parte o programa do vendedor
Receba PH
Pedidos
Programa do negociante do serviço do ouro
Receba RFP/PS
Pedidos
Fornecedores de Healthcare
Veja tudo
Ferramentas de HCP
Trabalhos/Treinamento
Achado/suficiência
Um trabalho
Parts Hunter +EasyPay
Comece as peças
Citações
Certificado recentemente
Vista recentemente
Usuários certificados
Recentemente Rated
Vista recentemente
Usuários certificados
Central Rental
Equipamento do aluguel
Para menos
Vender Equipamentos/Peças
Comece
A maioria de dinheiro
Preste serviços de manutenção ao Forum dos técnicos
Ajuda do achado
E conselho
Simples RFP
Comece o equipamento
Citações
Mostra de comércio virtual
Serviço do achado
Para o equipamento
O acesso e o uso deste local são sujeitos aos termos e às condições do nosso OBSERVAÇÃO LEGAL & OBSERVAÇÃO DA PRIVACIDADE
Propriedade de e proprietário DOTmeda .com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
TODOS OS DIREITOS RESERVADOS